List of Tables
Table 1. Global Gastrointestinal Drugs Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Gastrointestinal Drugs Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Gastrointestinal Drugs Market Competitive Situation by Manufacturers in 2025
Table 4. Global Gastrointestinal Drugs Sales (M Units) of Key Manufacturers (2021–2026)
Table 5. Global Gastrointestinal Drugs Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Gastrointestinal Drugs Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Gastrointestinal Drugs Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Gastrointestinal Drugs Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Gastrointestinal Drugs, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Gastrointestinal Drugs, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Gastrointestinal Drugs, Product Types and Applications
Table 12. Global Key Manufacturers of Gastrointestinal Drugs, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Gastrointestinal Drugs Companies by Tier (Tier 1, Tier 2, Tier 3), based on Gastrointestinal Drugs Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Gastrointestinal Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Gastrointestinal Drugs Sales by Region (M Units), 2021–2026
Table 18. Global Gastrointestinal Drugs Sales Market Share by Region (2021–2026)
Table 19. Global Gastrointestinal Drugs Sales by Region (M Units), 2027–2032
Table 20. Global Gastrointestinal Drugs Sales Market Share by Region (2027–2032)
Table 21. Global Gastrointestinal Drugs Revenue by Region (US$ Million), 2021–2026
Table 22. Global Gastrointestinal Drugs Revenue Market Share by Region (2021–2026)
Table 23. Global Gastrointestinal Drugs Revenue by Region (US$ Million), 2027–2032
Table 24. Global Gastrointestinal Drugs Revenue Market Share by Region (2027–2032)
Table 25. North America Gastrointestinal Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Gastrointestinal Drugs Sales by Country (M Units), 2021–2026
Table 27. North America Gastrointestinal Drugs Sales by Country (M Units), 2027–2032
Table 28. North America Gastrointestinal Drugs Revenue by Country (US$ Million), 2021–2026
Table 29. North America Gastrointestinal Drugs Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Gastrointestinal Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Gastrointestinal Drugs Sales by Country (M Units), 2021–2026
Table 32. Europe Gastrointestinal Drugs Sales by Country (M Units), 2027–2032
Table 33. Europe Gastrointestinal Drugs Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Gastrointestinal Drugs Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Gastrointestinal Drugs Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Gastrointestinal Drugs Sales by Region (M Units), 2021–2026
Table 37. Asia Pacific Gastrointestinal Drugs Sales by Region (M Units), 2027–2032
Table 38. Asia Pacific Gastrointestinal Drugs Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Gastrointestinal Drugs Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Gastrointestinal Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Gastrointestinal Drugs Sales by Country (M Units), 2021–2026
Table 42. Latin America Gastrointestinal Drugs Sales by Country (M Units), 2027–2032
Table 43. Latin America Gastrointestinal Drugs Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Gastrointestinal Drugs Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Gastrointestinal Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Gastrointestinal Drugs Sales by Country (M Units), 2021–2026
Table 47. Middle East and Africa Gastrointestinal Drugs Sales by Country (M Units), 2027–2032
Table 48. Middle East and Africa Gastrointestinal Drugs Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Gastrointestinal Drugs Revenue by Country (US$ Million), 2027–2032
Table 50. Global Gastrointestinal Drugs Sales (M Units) by Type (2021–2026)
Table 51. Global Gastrointestinal Drugs Sales (M Units) by Type (2027–2032)
Table 52. Global Gastrointestinal Drugs Sales Market Share by Type (2021–2026)
Table 53. Global Gastrointestinal Drugs Sales Market Share by Type (2027–2032)
Table 54. Global Gastrointestinal Drugs Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Gastrointestinal Drugs Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Gastrointestinal Drugs Revenue Market Share by Type (2021–2026)
Table 57. Global Gastrointestinal Drugs Revenue Market Share by Type (2027–2032)
Table 58. Global Gastrointestinal Drugs Price (US$/Unit) by Type (2021–2026)
Table 59. Global Gastrointestinal Drugs Price (US$/Unit) by Type (2027–2032)
Table 60. Global Gastrointestinal Drugs Sales (M Units) by Application (2021–2026)
Table 61. Global Gastrointestinal Drugs Sales (M Units) by Application (2027–2032)
Table 62. Global Gastrointestinal Drugs Sales Market Share by Application (2021–2026)
Table 63. Global Gastrointestinal Drugs Sales Market Share by Application (2027–2032)
Table 64. Global Gastrointestinal Drugs Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Gastrointestinal Drugs Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Gastrointestinal Drugs Revenue Market Share by Application (2021–2026)
Table 67. Global Gastrointestinal Drugs Revenue Market Share by Application (2027–2032)
Table 68. Global Gastrointestinal Drugs Price (US$/Unit) by Application (2021–2026)
Table 69. Global Gastrointestinal Drugs Price (US$/Unit) by Application (2027–2032)
Table 70. Takeda Company Information
Table 71. Takeda Description and Business Overview
Table 72. Takeda Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Takeda Gastrointestinal Drugs Product
Table 74. Takeda Recent Developments/Updates
Table 75. AstraZeneca Company Information
Table 76. AstraZeneca Description and Business Overview
Table 77. AstraZeneca Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. AstraZeneca Gastrointestinal Drugs Product
Table 79. AstraZeneca Recent Developments/Updates
Table 80. Bayer Company Information
Table 81. Bayer Description and Business Overview
Table 82. Bayer Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Bayer Gastrointestinal Drugs Product
Table 84. Bayer Recent Developments/Updates
Table 85. Pfizer Company Information
Table 86. Pfizer Description and Business Overview
Table 87. Pfizer Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Pfizer Gastrointestinal Drugs Product
Table 89. Pfizer Recent Developments/Updates
Table 90. Sun Pharma Company Information
Table 91. Sun Pharma Description and Business Overview
Table 92. Sun Pharma Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Sun Pharma Gastrointestinal Drugs Product
Table 94. Sun Pharma Recent Developments/Updates
Table 95. Teva Company Information
Table 96. Teva Description and Business Overview
Table 97. Teva Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Teva Gastrointestinal Drugs Product
Table 99. Teva Recent Developments/Updates
Table 100. Zeria Company Information
Table 101. Zeria Description and Business Overview
Table 102. Zeria Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Zeria Gastrointestinal Drugs Product
Table 104. Zeria Recent Developments/Updates
Table 105. Perrigo Company Information
Table 106. Perrigo Description and Business Overview
Table 107. Perrigo Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Perrigo Gastrointestinal Drugs Product
Table 109. Perrigo Recent Developments/Updates
Table 110. Eisai Co. Company Information
Table 111. Eisai Co. Description and Business Overview
Table 112. Eisai Co. Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Eisai Co. Gastrointestinal Drugs Product
Table 114. Eisai Co. Recent Developments/Updates
Table 115. Abbvie Company Information
Table 116. Abbvie Description and Business Overview
Table 117. Abbvie Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Abbvie Gastrointestinal Drugs Product
Table 119. Abbvie Recent Developments/Updates
Table 120. Jiangzhong Company Information
Table 121. Jiangzhong Description and Business Overview
Table 122. Jiangzhong Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Jiangzhong Gastrointestinal Drugs Product
Table 124. Jiangzhong Recent Developments/Updates
Table 125. AOSAIKANG Pharma Company Information
Table 126. AOSAIKANG Pharma Description and Business Overview
Table 127. AOSAIKANG Pharma Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. AOSAIKANG Pharma Gastrointestinal Drugs Product
Table 129. AOSAIKANG Pharma Recent Developments/Updates
Table 130. Luoxin Pharma Company Information
Table 131. Luoxin Pharma Description and Business Overview
Table 132. Luoxin Pharma Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. Luoxin Pharma Gastrointestinal Drugs Product
Table 134. Luoxin Pharma Recent Developments/Updates
Table 135. LIVZON Company Information
Table 136. LIVZON Description and Business Overview
Table 137. LIVZON Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 138. LIVZON Gastrointestinal Drugs Product
Table 139. LIVZON Recent Developments/Updates
Table 140. Eastchina Pharma Company Information
Table 141. Eastchina Pharma Description and Business Overview
Table 142. Eastchina Pharma Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 143. Eastchina Pharma Gastrointestinal Drugs Product
Table 144. Eastchina Pharma Recent Developments/Updates
Table 145. Bausch Health Company Information
Table 146. Bausch Health Description and Business Overview
Table 147. Bausch Health Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 148. Bausch Health Gastrointestinal Drugs Product
Table 149. Bausch Health Recent Developments/Updates
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Gastrointestinal Drugs Distributors List
Table 153. Gastrointestinal Drugs Customers List
Table 154. Gastrointestinal Drugs Market Trends
Table 155. Gastrointestinal Drugs Market Drivers
Table 156. Gastrointestinal Drugs Market Challenges
Table 157. Gastrointestinal Drugs Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
Table 161. Authors List of This Report
List of Figures
Figure 1. Product Picture of Gastrointestinal Drugs
Figure 2. Global Gastrointestinal Drugs Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Gastrointestinal Drugs Market Share by Type: 2025 & 2032
Figure 4. Prescription Product Picture
Figure 5. OTC Product Picture
Figure 6. Global Gastrointestinal Drugs Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Gastrointestinal Drugs Market Share by Application: 2025 & 2032
Figure 8. Inflammatory Bowel Disease
Figure 9. IBS Disease
Figure 10. Peptic Ulcer
Figure 11. GERD
Figure 12. Other
Figure 13. Global Gastrointestinal Drugs Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Gastrointestinal Drugs Market Size (US$ Million), 2021–2032
Figure 15. Global Gastrointestinal Drugs Sales (M Units), 2021–2032
Figure 16. Global Gastrointestinal Drugs Average Price (US$/Unit), 2021–2032
Figure 17. Gastrointestinal Drugs Report Years Considered
Figure 18. Gastrointestinal Drugs Sales Share by Manufacturers in 2025
Figure 19. Global Gastrointestinal Drugs Revenue Share by Manufacturers in 2025
Figure 20. Top 5 and Top 10 Global Gastrointestinal Drugs Players: Market Share by Revenue in Gastrointestinal Drugs in 2025
Figure 21. Gastrointestinal Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 22. Global Gastrointestinal Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 23. North America Gastrointestinal Drugs Sales Market Share by Country (2021–2032)
Figure 24. North America Gastrointestinal Drugs Revenue Market Share by Country (2021–2032)
Figure 25. United States Gastrointestinal Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Canada Gastrointestinal Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. Europe Gastrointestinal Drugs Sales Market Share by Country (2021–2032)
Figure 28. Europe Gastrointestinal Drugs Revenue Market Share by Country (2021–2032)
Figure 29. Germany Gastrointestinal Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. France Gastrointestinal Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. U.K. Gastrointestinal Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Italy Gastrointestinal Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Russia Gastrointestinal Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Asia Pacific Gastrointestinal Drugs Sales Market Share by Region (2021–2032)
Figure 35. Asia Pacific Gastrointestinal Drugs Revenue Market Share by Region (2021–2032)
Figure 36. China Gastrointestinal Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Japan Gastrointestinal Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. South Korea Gastrointestinal Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. India Gastrointestinal Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Australia Gastrointestinal Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. China Taiwan Gastrointestinal Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Southeast Asia Gastrointestinal Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Latin America Gastrointestinal Drugs Sales Market Share by Country (2021–2032)
Figure 44. Latin America Gastrointestinal Drugs Revenue Market Share by Country (2021–2032)
Figure 45. Mexico Gastrointestinal Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Brazil Gastrointestinal Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Argentina Gastrointestinal Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Middle East and Africa Gastrointestinal Drugs Sales Market Share by Country (2021–2032)
Figure 49. Middle East and Africa Gastrointestinal Drugs Revenue Market Share by Country (2021–2032)
Figure 50. Turkey Gastrointestinal Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Saudi Arabia Gastrointestinal Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. UAE Gastrointestinal Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Global Sales Market Share of Gastrointestinal Drugs by Type (2021–2032)
Figure 54. Global Revenue Market Share of Gastrointestinal Drugs by Type (2021–2032)
Figure 55. Global Gastrointestinal Drugs Price (US$/Unit) by Type (2021–2032)
Figure 56. Global Sales Market Share of Gastrointestinal Drugs by Application (2021–2032)
Figure 57. Global Revenue Market Share of Gastrointestinal Drugs by Application (2021–2032)
Figure 58. Global Gastrointestinal Drugs Price (US$/Unit) by Application (2021–2032)
Figure 59. Gastrointestinal Drugs Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
